BioCentury
ARTICLE | Company News

OxiGene deal

December 15, 2008 8:00 AM UTC

Symphony Capital Partners L.P. exercised its warrant to purchase 11.3 million OxiGene shares at $1.11, for a total of $12.5 million in cash. Symphony gained the warrant in its October deal with OxiGen...